In a report released today, Alex Fuhrman from Craig-Hallum assigned a Buy rating to LifeVantage (LFVN – Research Report). The company’s shares ...

The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients ...

The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

The company adopted its current name in November 2006. Initially focused on selling a single product, Protandim, through traditional retail stores from 2005 to 2009, LifeVantage transitioned to a ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.

Preliminary Second Quarter Fiscal 2025 Highlights: Revenue of approximately $67.5 million, an increase of 31% from the prior year period, and up 43% sequentially from the first fiscal quarter ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.